Global Prosthetic Heart Valve & Artificial Heart Valve Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prosthetic Heart Valve & Artificial Heart Valve Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Prosthetic Heart Valve & Artificial Heart Valve report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prosthetic Heart Valve & Artificial Heart Valve market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Rheumatic Heart Disease and Congenital Heart Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prosthetic Heart Valve & Artificial Heart Valve industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prosthetic Heart Valve & Artificial Heart Valve key manufacturers include Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc. and Ttk Healthcare Limited, etc. Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company) are top 3 players and held % sales share in total in 2022.
Prosthetic Heart Valve & Artificial Heart Valve can be divided into Transcatheter Heart Valve, Tissue Heart Valve and Mechanical Heart Valve,, etc. Transcatheter Heart Valve is the mainstream product in the market, accounting for % sales share globally in 2022.
Prosthetic Heart Valve & Artificial Heart Valve is widely used in various fields, such as Rheumatic Heart Disease, Congenital Heart Disease, Marfan Syndrome and Other, etc. Rheumatic Heart Disease provides greatest supports to the Prosthetic Heart Valve & Artificial Heart Valve industry development. In 2022, global % sales of Prosthetic Heart Valve & Artificial Heart Valve went into Rheumatic Heart Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prosthetic Heart Valve & Artificial Heart Valve market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Edwards Lifesciences Corporation
Medtronic Plc
St. Jude Medical Inc.(Abbott Laboratories Company)
Boston Scientific Corporation
Livanova Plc
Symetis
Jenavalve Technology Inc.
Cryolife Inc.
Ttk Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional Devices
Autotissue Berlin Gmbh
Comed B.V.
Meril Life Sciences
Labcor Laboratório
HLT Inc.(A Bracco Group Company)
Medtronic
Edwards Lifesciences Corporation
Boston Scientific Corporation
Livanova Plc
St. Jude Medical, Inc.(An Abbott Laboratories Company)
Symetis Sa
Jenavalve Technology, Inc.
Cryolife, Inc.
TTK Healthcare Limited(A Ttk Group Company)
Colibri Heart Valve, Llc
Lepu Medical Technology Co., Ltd.
Braile Biomédica
Segment by Type
Transcatheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve
Rheumatic Heart Disease
Congenital Heart Disease
Marfan Syndrome
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prosthetic Heart Valve & Artificial Heart Valve market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prosthetic Heart Valve & Artificial Heart Valve, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prosthetic Heart Valve & Artificial Heart Valve industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prosthetic Heart Valve & Artificial Heart Valve in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prosthetic Heart Valve & Artificial Heart Valve introduction, etc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prosthetic Heart Valve & Artificial Heart Valve market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Prosthetic Heart Valve & Artificial Heart Valve industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prosthetic Heart Valve & Artificial Heart Valve key manufacturers include Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc. and Ttk Healthcare Limited, etc. Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company) are top 3 players and held % sales share in total in 2022.
Prosthetic Heart Valve & Artificial Heart Valve can be divided into Transcatheter Heart Valve, Tissue Heart Valve and Mechanical Heart Valve,, etc. Transcatheter Heart Valve is the mainstream product in the market, accounting for % sales share globally in 2022.
Prosthetic Heart Valve & Artificial Heart Valve is widely used in various fields, such as Rheumatic Heart Disease, Congenital Heart Disease, Marfan Syndrome and Other, etc. Rheumatic Heart Disease provides greatest supports to the Prosthetic Heart Valve & Artificial Heart Valve industry development. In 2022, global % sales of Prosthetic Heart Valve & Artificial Heart Valve went into Rheumatic Heart Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prosthetic Heart Valve & Artificial Heart Valve market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Edwards Lifesciences Corporation
Medtronic Plc
St. Jude Medical Inc.(Abbott Laboratories Company)
Boston Scientific Corporation
Livanova Plc
Symetis
Jenavalve Technology Inc.
Cryolife Inc.
Ttk Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional Devices
Autotissue Berlin Gmbh
Comed B.V.
Meril Life Sciences
Labcor Laboratório
HLT Inc.(A Bracco Group Company)
Medtronic
Edwards Lifesciences Corporation
Boston Scientific Corporation
Livanova Plc
St. Jude Medical, Inc.(An Abbott Laboratories Company)
Symetis Sa
Jenavalve Technology, Inc.
Cryolife, Inc.
TTK Healthcare Limited(A Ttk Group Company)
Colibri Heart Valve, Llc
Lepu Medical Technology Co., Ltd.
Braile Biomédica
Segment by Type
Transcatheter Heart Valve
Tissue Heart Valve
Mechanical Heart Valve
Segment by Application
Rheumatic Heart Disease
Congenital Heart Disease
Marfan Syndrome
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prosthetic Heart Valve & Artificial Heart Valve market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prosthetic Heart Valve & Artificial Heart Valve, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prosthetic Heart Valve & Artificial Heart Valve industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prosthetic Heart Valve & Artificial Heart Valve in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prosthetic Heart Valve & Artificial Heart Valve introduction, etc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prosthetic Heart Valve & Artificial Heart Valve market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices